Michael Thompson
AI-Enhanced View57M • MRN: 784321 • DOB: 06/12/1968 • Primary: Dr. Sarah Chen
AI-Generated Clinical Narrative
Mr. Thompson is a 57-year-old male with a complex cardiovascular history including hypertension (diagnosed 2015), hyperlipidemia (diagnosed 2017), and coronary artery disease with stent placement (2023). His blood pressure has been variably controlled, showing improvement after medication adjustments in January 2024 but with recent elevations. Lab trends show gradually worsening kidney function (eGFR decline from 75 to 58 over 18 months) that correlates with periods of uncontrolled hypertension. Patient had an adverse reaction to lisinopril (cough) and was switched to losartan with improved tolerance. Recent cardiac stress test (February 2025) shows mild ischemia that may warrant follow-up.
Patient Clinical Timeline
Hospital Admission
Jun 12, 2023Admitted with chest pain and shortness of breath. Coronary angiography performed with stent placement to LAD.
Medication Change
Aug 23, 2023Started on dual antiplatelet therapy: Aspirin 81mg daily and Clopidogrel 75mg daily post-stent placement.
Adverse Reaction
Nov 5, 2023Developed persistent dry cough with Lisinopril. Reported during telehealth visit.
Medication Change
Jan 15, 2024Lisinopril discontinued. Started on Losartan 50mg daily for hypertension management.
Appropriate medication switch due to ACE inhibitor-induced cough. BP improved from 148/92 to 134/82 within 3 weeks of change.
Cardiac Stress Test
Feb 20, 2025Exercise stress test showed mild reversible ischemia in the anterolateral wall.
Findings suggest possible progression from prior stent area. Correlation with recent reports of exertional chest discomfort.
Key Clinical Measures Over Time
AI-Detected Correlations & Predictions
AI AnalysisDetected Correlations
-
Strong correlation between periods of uncontrolled hypertension and declining kidney function (eGFR drop).
Confidence: 92% -
Medication adherence decreases during holiday seasons (Nov-Dec), correlating with BP increases.
Confidence: 88% -
Reported chest discomfort episodes correlate with periods of elevated blood pressure (>140/90).
Confidence: 85%
Clinical Predictions
-
High risk (76%) of requiring cardiac catheterization within 6 months based on recent stress test findings and symptom progression.
Confidence: 85% -
Moderate risk (62%) of transitioning to stage 3 CKD within 12 months if blood pressure remains above target.
Confidence: 78% -
Predicted benefit from increasing statin dosage based on lipid profile trend and cardiac history.
Confidence: 91%